Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Axsome Thera (AXSM)

Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,083,705
  • Shares Outstanding, K 47,496
  • Annual Sales, $ 270,600 K
  • Annual Income, $ -239,240 K
  • 60-Month Beta 1.26
  • Price/Sales 14.96
  • Price/Cash Flow N/A
  • Price/Book 28.25
Trade AXSM with:

Options Overview Details

View History
  • Implied Volatility 44.78% ( -2.87%)
  • Historical Volatility 28.89%
  • IV Percentile 19%
  • IV Rank 27.82%
  • IV High 66.84% on 10/24/23
  • IV Low 36.27% on 05/16/24
  • Put/Call Vol Ratio 0.21
  • Today's Volume 377
  • Volume Avg (30-Day) 1,030
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 25,397
  • Open Int (30-Day) 23,512

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -1.30
  • Number of Estimates 9
  • High Estimate -0.91
  • Low Estimate -1.67
  • Prior Year -1.00
  • Growth Rate Est. (year over year) -30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
76.00 +13.86%
on 06/27/24
87.38 -0.97%
on 07/23/24
+9.41 (+12.20%)
since 06/26/24
3-Month
64.11 +34.97%
on 06/11/24
87.38 -0.97%
on 07/23/24
+14.82 (+20.67%)
since 04/26/24
52-Week
55.02 +57.27%
on 11/13/23
98.40 -12.06%
on 02/12/24
+10.33 (+13.56%)
since 07/26/23

Most Recent Stories

More News
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected

EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NASDAQ:AXSM) EQNX::TICKER_END

TNXP : 0.5500 (-5.09%)
LLY : 804.62 (-2.02%)
PFE : 30.77 (+3.39%)
ABBV : 185.16 (+1.64%)
AXSM : 86.53 (+0.64%)
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected

TNXP : 0.5500 (-5.09%)
LLY : 804.62 (-2.02%)
PFE : 30.77 (+3.39%)
ABBV : 185.16 (+1.64%)
AXSM : 86.53 (+0.64%)
Bull Market and Beyond: 2 Stocks Just Waiting to Soar

These innovative drugmakers are hard to ignore.

VRTX : 495.26 (+0.61%)
AXSM : 86.53 (+0.64%)
Should You Buy This Sinking Stock on the Dip?

The biotech isn't having the best year.

AXSM : 86.53 (+0.64%)
Why Axsome Therapeutics Stock Is Sinking Today

A short-seller report is causing a sell-off of the biotech stock.

AXSM : 86.53 (+0.64%)
3 Monster Stocks in the Making You Can Buy Right Now

These stocks might not be small for too much longer.

GS : 499.03 (+1.49%)
LLY : 804.62 (-2.02%)
ALT : 6.75 (+0.90%)
AXSM : 86.53 (+0.64%)
VKTX : 65.98 (+2.01%)
Prediction: These 2 Growth Stocks Could Triple By 2030

These companies have a habit of silencing the bears.

AXSM : 86.53 (+0.64%)
SHOP : 59.94 (+0.84%)
Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript

AXSM earnings call for the period ending March 31, 2024.

AXSM : 86.53 (+0.64%)
Axsome: Q1 Earnings Snapshot

Axsome: Q1 Earnings Snapshot

AXSM : 86.53 (+0.64%)
Billionaires Are Buying These 2 Ultra-High Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio?

Stocks that work for billionaires aren't necessarily appropriate for every investor.

PLTR : 27.18 (+2.07%)
AXSM : 86.53 (+0.64%)
TMDX : 140.49 (-3.77%)
HTGC : 21.43 (+1.42%)
MO : 50.43 (+1.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS), disorders for which there are limited treatment options available.

See More

Key Turning Points

3rd Resistance Point 89.17
2nd Resistance Point 88.05
1st Resistance Point 87.29
Last Price 86.53
1st Support Level 85.41
2nd Support Level 84.29
3rd Support Level 83.53

See More

52-Week High 98.40
Last Price 86.53
Fibonacci 61.8% 81.83
Fibonacci 50% 76.71
Fibonacci 38.2% 71.59
52-Week Low 55.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar